142 related articles for article (PubMed ID: 22931894)
1. MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy.
Henríquez-Hernández LA; Moreno M; Rey A; Lloret M; Lara PC
Radiat Oncol; 2012 Aug; 7():147. PubMed ID: 22931894
[TBL] [Abstract][Full Text] [Related]
2. MVP expression is related to IGF1-R in cervical carcinoma patients treated by radiochemotherapy.
Lloret M; Lara PC; Bordón E; Rey A; Falcón O; Apolinario RM; Clavo B; Ruiz A
Gynecol Oncol; 2008 Sep; 110(3):304-7. PubMed ID: 18599112
[TBL] [Abstract][Full Text] [Related]
3. IGF-1R expression predicts clinical outcome in patients with locally advanced oral squamous cell carcinoma.
Lara PC; Bordón E; Rey A; Moreno M; Lloret M; Henríquez-Hernández LA
Oral Oncol; 2011 Jul; 47(7):615-9. PubMed ID: 21640634
[TBL] [Abstract][Full Text] [Related]
4. BCL-2, in combination with MVP and IGF-1R expression, improves prediction of clinical outcome in complete response cervical carcinoma patients treated by radiochemotherapy.
Henríquez-Hernández LA; Lloret M; Pinar B; Bordón E; Rey A; Lubrano A; Lara PC
Gynecol Oncol; 2011 Sep; 122(3):585-9. PubMed ID: 21708403
[TBL] [Abstract][Full Text] [Related]
5. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
6. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.
Silva P; West CM; Slevin N; Valentine H; Ryder WD; Hampson L; Bibi R; Sloan P; Thakker N; Homer J; Hampson I
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):133-40. PubMed ID: 17459603
[TBL] [Abstract][Full Text] [Related]
7. Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.
Lara PC; Lloret M; Clavo B; Apolinario RM; Henríquez-Hernández LA; Bordón E; Fontes F; Rey A
Radiat Oncol; 2009 Aug; 4():29. PubMed ID: 19660100
[TBL] [Abstract][Full Text] [Related]
8. IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy.
Lloret M; Lara PC; Bordón E; Pinar B; Rey A; Falcón O; Molano F; Hernández MA
Gynecol Oncol; 2007 Jul; 106(1):8-11. PubMed ID: 17490736
[TBL] [Abstract][Full Text] [Related]
9. Major vault protein may affect nonhomologous end-joining repair and apoptosis through Ku70/80 and bax downregulation in cervical carcinoma tumors.
Lloret M; Lara PC; Bordón E; Fontes F; Rey A; Pinar B; Falcón O
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):976-9. PubMed ID: 19251084
[TBL] [Abstract][Full Text] [Related]
10. IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.
Dale OT; Aleksic T; Shah KA; Han C; Mehanna H; Rapozo DC; Sheard JD; Goodyear P; Upile NS; Robinson M; Jones TM; Winter S; Macaulay VM
Carcinogenesis; 2015 Jun; 36(6):648-55. PubMed ID: 25896444
[TBL] [Abstract][Full Text] [Related]
11. Major vault protein/lung resistance-related protein (MVP/LRP) expression in nervous system tumors.
Sasaki T; Hankins GR; Helm GA
Brain Tumor Pathol; 2002; 19(2):59-62. PubMed ID: 12622134
[TBL] [Abstract][Full Text] [Related]
12. GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Lin CY; Lin TY; Wang HM; Huang SF; Fan KH; Liao CT; Chen IH; Lee LY; Li YL; Chen YJ; Cheng AJ; Chang JT
Radiat Oncol; 2011 Oct; 6():136. PubMed ID: 21992474
[TBL] [Abstract][Full Text] [Related]
13. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Alsner J; Sørensen SB; Overgaard J
Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447
[TBL] [Abstract][Full Text] [Related]
15. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
16. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
17. Role of combined modality treatment of buccal mucosa squamous cell carcinoma.
Lee KH; Veness MJ; Pearl-Larson T; Morgans GJ
Aust Dent J; 2005 Jun; 50(2):108-13. PubMed ID: 16050090
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
19. Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results.
Kirita T; Ohgi K; Shimooka H; Yamanaka Y; Tatebayashi S; Yamamoto K; Mishima K; Sugimura M
Oral Oncol; 1999 Nov; 35(6):597-606. PubMed ID: 10705096
[TBL] [Abstract][Full Text] [Related]
20. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
Matsumoto F; Ohba S; Fujimaki M; Ikeda K
Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
